Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioFire Defense
Salt Lake City, Utah, United Statesbiofiredefense.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
BioFire Defense develops and manufactures rapid PCR-based diagnostic systems for the detection and identification of biological threat agents and infectious diseases. Their products are widely used by the U.S. Department of Defense and other government agencies for field-deployable biothreat surveillance as well as in commercial markets for rapid pathogen detection[1][2][4].
- Therapeutic areas
- Infectious Diseases
- Modalities
- DevicePCR-based molecular diagnostics
- Industry
- Molecular Diagnostics
02
Partnerships
U.S. Department of Defense and other U.S. government agencies
Beyond the preview
Go deeper on BioFire Defense.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BioFire Defense.